US › Healthcare

Onconetix Inc (ONCO)

US · Healthcare · Biotechnology

$0.66+0.15%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$17,120

Revenue YoY

-83.9%

Net profit

$-2.9M

EPS

$-1.28

Net margin

-16,748.3%

Key statistics

Market cap

$2.8M

P/E

0.0

Forward P/E

0.0

P/B

0.21

Book value

$3.55

EPS (TTM)

$749.08

52-week high

$209.50

52-week low

$0.59

50-day MA

$0.80

200-day MA

$29.90

Beta

2.67

Analyst view

Analysts rate Onconetix Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $9.00.

Shareholding

Insiders

0.15%

Institutions

6.61%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.10%
Citigroup Inc	0.01%
UBS Group AG	0.01%
Tower Research Capital LLC	0.01%
SBI Securities Co Ltd	0.00%
DRW Securities, LLC	0.00%
Danske Bank A/S.	0.00%
XTX Topco Ltd	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Onconetix Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.